tiprankstipranks
Trending News
More News >
COSMO Pharmaceuticals N.V. (GB:0RGI)
LSE:0RGI
UK Market

COSMO Pharmaceuticals N.V. (0RGI) Income Statement

Compare
11 Followers

COSMO Pharmaceuticals N.V. Income Statement

Last quarter (Q4 2024), COSMO Pharmaceuticals N.V.'s total revenue was €130.55M, an increase of 115.51% from the same quarter last year. In Q4, COSMO Pharmaceuticals N.V.'s net income was €57.24M. See COSMO Pharmaceuticals N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 266.79M€ 92.78M€ 102.09M€ 65.07M€ 60.95M
Gross Profit
€ 246.92M€ 53.44M€ 83.33M€ 49.93M€ 50.51M
Operating Expenses
€ 98.04M€ 47.29M€ 55.27M€ 38.83M€ 43.60M
Depreciation and Amortization
€ 12.29M€ 13.55M€ 13.86M€ 7.37M€ 6.04M
EBITDA
€ 165.71M€ 19.70M€ 47.49M€ 40.48M€ 7.84M
Operating Income
€ 148.88M€ 6.15M€ 28.06M€ 33.11M€ 2.06M
Other Income/Expenses
€ 4.49M€ -4.61M€ -3.58M€ -9.11M€ -13.84M
Pretax Income
€ 153.37M€ 1.53M€ 24.47M€ 24.00M€ -6.93M
Net Income
€ 133.24M€ -4.93M€ 17.23M€ 21.67M€ -7.90M
Per Share Metrics
Basic EPS
€ 8.15€ -0.31€ 1.05€ 1.29€ -0.55
Diluted EPS
€ 8.12€ -0.31€ 1.05€ 1.28€ -0.55
Weighted Average Shares Outstanding
16.36M 16.11M 16.43M 16.84M 14.47M
Weighted Average Shares Outstanding (Diluted)
16.42M 16.11M 16.43M 16.90M 14.47M
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis